drugIndia
Cart
Mpride V1 Tablet SR

Mpride V1 Tablet SR

Metformin (500mg) + Glimepiride (1mg) + Voglibose (0.2mg)

Ajanta Pharma Ltd
Anti-Diabetic
168.75210.9420% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 81%
Best Alternative100% Match

Glimison-VM 1 Tablet SR

Unison Pharmaceuticals Pvt Ltd

Voglibose 0.2mg
Glimison-VM 1 Tablet SR

Pack Size

1 units

Price

31.6020% off
Glimison-VM 1 Tablet SR is 100% same as Mpride V1 Tablet SR
Better ValueSame QualitySame Effectiveness

Save ₹137

that's 81% off!

composition
  1. Voglibose 0.2mg
  2. Glimepiride 1mg
  3. Metformin 500mg
Buy Now
168.7520% OFF
210.94

About This Medicine

Product description & overview

Mpride V1 Tablet SR: A Powerful Combination Therapy

Mpride V1 Tablet SR combines a precise blend of three key ingredients to manage Type 2 Diabetes effectively: Glimepiride (1mg), Metformin (500mg), and Voglibose (0.2mg). This carefully formulated tablet provides comprehensive control over blood sugar levels by targeting multiple metabolic pathways.

Glimepiride: Reduces the production of glucose in the liver, lowering postprandial blood sugar spikes.
Metformin: Decreases hepatic glucose production and improves insulin sensitivity for overall blood glucose regulation.
Voglibose: Specifically slows down gastric emptying, enhancing the effectiveness of other medications by ensuring a more consistent absorption of glucose into the bloodstream.

Mpride V1 Tablet SR offers convenient extended-release formulation, allowing for gradual release over time to ensure steady blood sugar control without frequent dosing. This medication is prescribed by healthcare professionals to manage Type 2 Diabetes and is only available with a prescription.

Please note: This description is intended for informational purposes only and does not constitute medical advice. Consult your doctor or pharmacist for personalized guidance regarding this medication.

Active composition

Metformin 500 mg

+2 more active ingredients

About Metformin

Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.

How It Works

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Medicine Strength
500 mg

All Active Ingredients

Metformin500 mg
Glimepiride1 mg
Voglibose0.2 mg

Glimepiride

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Mpride V1 Tablet SR.

High Risk

Pregnancy

Mpride V1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Mpride V1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Mpride V1 Tablet SR may be needed. Please consult your doctor. Mpride V1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Mpride V1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Mpride V1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Mpride V1 Tablet SR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Mpride V1 Tablet SR

Products matching your search